Lisa Rohan
 | This article, Lisa Rohan, has recently been created via the Articles for creation process. Please check to see if the reviewer has accidentally left this template after accepting the draft and take appropriate action as necessary.
Reviewer tools: Inform author |
| This article, Lisa Rohan, has recently been created via the Articles for creation process. Please check to see if the reviewer has accidentally left this template after accepting the draft and take appropriate action as necessary.
Reviewer tools: Inform author |
Comment: Does not appear to meet WP:NACADEMIC. Scholarly impact should be demonstrated in independent, reliable sources (not their ResearchGate profile). -Liancetalk/contribs 00:07, 12 March 2022 (UTC)
Lisa Cencia Rohan is an American chemist and pharmaceutical scientist. She obtained a Bachelor of Science in Chemical Engineering from West Virginia University and a Ph.D. in Pharmaceutics from the University of Pittsburgh, School of Pharmacy. She completed a Postdoctoral Fellowship in the Department of Obstetrics, Gynecology, and Reproductive Sciences in the area of Mucosal Immunology at the University of Pittsburgh. By far, Dr. Lisa Rohan has 169 publications with over 3,000 citations[1][2][3][4][5]. Prior to her academic career, Rohan held leadership positions in the pharmaceutical industry.
Rohan currently serves on the faculty as a Professor in the Department of Pharmaceutical Sciences in the School of Pharmacy.[6] She also holds appointments in the Department of Obstetrics, Gynecology, and Reproductive Sciences in the School of Medicine and the Clinical Translational Science Institute at the University of Pittsburgh.[7] Additionally, she is an Investigator at the Magee Womens Research Institute.[8] Rohan serves as co-principal investigator for the Microbicide Trials Network Laboratory[9], an HIV/AIDS clinical trials network established by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health (NIH).
The primary focus of the research in the lab is centered on the design of drug delivery systems for application in the areas of infectious disease, irritable bowel syndrome, and gynecologic oncology. A recent on-going development involves the development of a drug delivery system for the prevention of COVID-19.[10] This work done by her and her research team, fighting the COVID-19 pandemic, was covered by the Pittsburgh Business Times[10], the Pittsburgh's Action News 4 (WTAE)[11], and other local media.[12]
References
- ^ "Citation Report_Lisa C. Rohan_Web of Science". Web of Science. Retrieved 2022-05-05.
- ^ "Rohan LC - Search Results - PubMed". PubMed. Retrieved 2022-05-05.
- ^ "ResearchGate_Profile_LisaRohan". ResearchGate. Retrieved 2022-01-27.
{{cite web}}: CS1 maint: url-status (link) - ^ "Lisa Rohan". scholar.google.com. Retrieved 2022-05-05.
- ^ "Lisa C. Rohan - Publications". academictree.org. Retrieved 2022-05-05.
- ^ "Directory Profile: University of Pittsburgh School of Pharmacy". www.pharmacy.pitt.edu. Retrieved 2022-01-27.
- ^ Foundation, Magee-Womens Research Institute &. "Lisa Cencia Rohan, PhD". Magee-Womens Research Institute & Foundation. Retrieved 2022-01-27.
- ^ Foundation, Magee-Womens Research Institute &. "Lisa Cencia Rohan, PhD". Magee-Womens Research Institute & Foundation. Retrieved 2022-01-27.
- ^ "Lisa Rohan". mtnstopshiv.org. Retrieved 2022-01-27.
- ^ a b Doughty, Nate (Dec 23, 2021). "Faces of Resilience: Dr. Lisa Rohan, Magee-Womens Research Institute and Foundation". www.bizjournals.com. Retrieved 2022-01-27.
- ^ Wright, Michelle, Nasal Spray to fight COVID-19, retrieved 2022-05-05
- ^ "Rohan Stepping Up to Challenge: Prevent COVID-19 Infection – ePittPharmacy". Retrieved 2022-05-05.